Stay updated on EAP Nusinersen in Infantile-onset SMA Clinical Trial
Sign up to get notified when there's something new on the EAP Nusinersen in Infantile-onset SMA Clinical Trial page.

Latest updates to the EAP Nusinersen in Infantile-onset SMA Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about the Expanded Access Program (EAP) for nusinersen treatment for Infantile-onset Spinal Muscular Atrophy (SMA), which is critical for patient access. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference24%
Stay in the know with updates to EAP Nusinersen in Infantile-onset SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Nusinersen in Infantile-onset SMA Clinical Trial page.